[1]
G. Blackhouse, “CANADIAN COST-UTILITY ANALYSIS OF INTRAVENOUS IMMUNOGLOBULIN FOR ACUTE CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA”, J Popl Ther Clin Pharmacol, vol. 19, no. 2, Nov. 2018, Accessed: Oct. 07, 2026. [Online]. Available: https://www.jptcp.com/index.php/jptcp/article/view/420